Feng Gu

4.3k total citations
146 papers, 3.2k citations indexed

About

Feng Gu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Feng Gu has authored 146 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 45 papers in Oncology and 37 papers in Cancer Research. Recurrent topics in Feng Gu's work include Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (13 papers) and Cell Adhesion Molecules Research (12 papers). Feng Gu is often cited by papers focused on Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (13 papers) and Cell Adhesion Molecules Research (12 papers). Feng Gu collaborates with scholars based in China, United States and Japan. Feng Gu's co-authors include Li Fu, Ronggang Lang, Yongjie Ma, Xinmin Zhang, Xiaojing Guo, Li Fu, Yu Fan, Li Fu, Gordon A. Pringle and Fangfang Liu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Feng Gu

140 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Feng Gu China 34 1.6k 1.0k 989 494 328 146 3.2k
Tiziana Annese Italy 30 1.7k 1.1× 800 0.8× 772 0.8× 548 1.1× 261 0.8× 99 3.2k
Tatsuya Ozawa Japan 26 1.7k 1.0× 1.0k 1.0× 1.2k 1.2× 362 0.7× 177 0.5× 49 3.5k
Amyn A. Habib United States 32 1.7k 1.1× 831 0.8× 667 0.7× 605 1.2× 203 0.6× 56 3.1k
Zhenhe Suo Norway 32 1.8k 1.1× 1.3k 1.3× 872 0.9× 273 0.6× 182 0.6× 107 3.1k
Bernd Hinzmann Germany 24 1.7k 1.0× 808 0.8× 958 1.0× 361 0.7× 249 0.8× 47 3.0k
Lin Cheng China 25 1.9k 1.1× 990 1.0× 784 0.8× 465 0.9× 121 0.4× 75 3.4k
Silke Laßmann Germany 31 1.2k 0.7× 1.1k 1.1× 431 0.4× 453 0.9× 387 1.2× 87 2.7k
Norbert Schweifer Austria 28 2.8k 1.7× 1.1k 1.1× 660 0.7× 428 0.9× 283 0.9× 46 4.0k
David Jin United States 23 1.6k 1.0× 1.3k 1.3× 619 0.6× 480 1.0× 122 0.4× 48 3.4k
Benilde Jiménez Spain 28 2.2k 1.3× 568 0.6× 841 0.9× 356 0.7× 210 0.6× 49 3.1k

Countries citing papers authored by Feng Gu

Since Specialization
Citations

This map shows the geographic impact of Feng Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Gu more than expected).

Fields of papers citing papers by Feng Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feng Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Gu. The network helps show where Feng Gu may publish in the future.

Co-authorship network of co-authors of Feng Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Feng Gu. A scholar is included among the top collaborators of Feng Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Feng Gu. Feng Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Jiahao, Muchao Chen, Feng Gu, et al.. (2025). In situ formed chemo-immunotherapeutic hydrogel for suppression of postoperative glioma recurrence and intraoperative hemostasis. Journal of Controlled Release. 387. 114168–114168.
2.
Liang, Mengmeng, Yingying Meng, Ying Zhu, et al.. (2024). Application of OSCE-Based Escape Room Approach in Clinical Practice of Nursing Interns in the Department of Gastroenterology. Journal of Biosciences and Medicines. 12(12). 10–21. 2 indexed citations
3.
Zhang, Huikun, Xiaoli Liu, Yongzi Chen, et al.. (2023). Water channel protein AQP1 in cytoplasm is a critical factor in breast cancer local invasion. Journal of Experimental & Clinical Cancer Research. 42(1). 49–49. 16 indexed citations
4.
Fang, Jian, Fanpeng Zeng, Yongqiang Chen, et al.. (2022). The role of hypoxic mesenchymal stem cells in tumor immunity. International Immunopharmacology. 112. 109172–109172. 7 indexed citations
5.
Gu, Feng, et al.. (2020). Distinct functions and prognostic values of RORs in gastric cancer. Open Medicine. 15(1). 424–434. 1 indexed citations
7.
Gu, Feng, Chong Wang, Fang Wei, et al.. (2018). STAT6 degradation and ubiquitylated TRIML2 are essential for activation of human oncogenic herpesvirus. PLoS Pathogens. 14(12). e1007416–e1007416. 13 indexed citations
8.
Zhang, Chao, Yu Fan, Weidong Li, et al.. (2013). Expression and significance of Ll-CAM in invasive micropapillary carcinoma of the breast. Clinical Oncology and Cancer Research. 40(4). 198–201. 2 indexed citations
9.
Xiong, Guangyao, et al.. (2013). A Novel <i>in Vitro</i> Three-Dimensional Macroporous Scaffolds from Bacterial Cellulose for Culture of Breast Cancer Cells. Journal of Biomaterials and Nanobiotechnology. 4(4). 316–326. 23 indexed citations
10.
Ding, Ting, Minghao Yin, Kai Sun, et al.. (2013). Knockdown a Water Channel Protein, Aquaporin-4, Induced Glioblastoma Cell Apoptosis. PLoS ONE. 8(8). e66751–e66751. 39 indexed citations
11.
Zhang, Bin, Fangfang Liu, Yongjie Ma, & Feng Gu. (2013). [Cytoplasmic expression of aquaporin-1 in breast cancer cells and its relationship with clinicopathological characteristics and prognosis].. PubMed. 35(12). 904–9. 3 indexed citations
12.
Fu, Li, et al.. (2012). [Expression and significance of phosphorylated Girdin in breast cancer].. PubMed. 34(3). 205–9. 1 indexed citations
13.
Yang, Yi-Ling, et al.. (2012). Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance. Breast Cancer Research and Treatment. 134(3). 1095–1102. 34 indexed citations
14.
Gu, Feng, et al.. (2011). Research progression of mechanisms in glioma chemoresistance. Zhonghua zhongliu fangzhi zazhi. 18(7). 551–556. 1 indexed citations
15.
Gu, Feng, et al.. (2011). Co-culture with microglia promotes neural stem cells differentiation into astrocytes.. PubMed. 124(20). 3394–8. 9 indexed citations
16.
Zhang, Han, Zheli Liu, Peng Sun, & Feng Gu. (2011). Intravitreal Bevacizumab for Treatment of Macular Edema Secondary to Central Retinal Vein Occlusion: Eighteen-Month Results of a Prospective Trial. Journal of Ocular Pharmacology and Therapeutics. 27(6). 615–621. 27 indexed citations
17.
Wang, Jing, Feng Gu, Ting Ding, et al.. (2010). [Gd@C82(OH)22]n nanoparticles inhibit the migration and adhesion of glioblastoma cells. Oncology Letters. 1(4). 771–775. 6 indexed citations
18.
Zhang, Baogang, Feng Gu, Hua Guo, et al.. (2009). Reduction of Akt2 inhibits migration and invasion of glioma cells. International Journal of Cancer. 125(3). 585–595. 72 indexed citations
19.
Zhao, Jing, Ronggang Lang, Xiaojing Guo, et al.. (2009). Clinicopathologic characteristics of pleomorphic carcinoma of the breast. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 456(1). 31–37. 10 indexed citations
20.
Liu, Fangfang, et al.. (2008). [Significance of expression of stromal cell derived factor 1 and CXCR4 in invasive breast cancer].. PubMed. 37(8). 529–35. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026